The Phase 1 study is a single-ascending dose trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of LRK-4189 in healthy volunteers. The United Kingdom-based study expects ...

ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...

Pancreatic cancer is among the most aggressive and treatment-resistant malignancies, with a five-year survival rate below 12%. Central to its pathology is the overexpression of c-MYC, a transcription ...

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- UTR Therapeutics Inc., a biotechnology company advancing a novel RNA Overwriting platform, today announced the peer-reviewed publication of preclinical ...

Gain first-hand experience of the latest experimental approaches in pharmacology and drug development, on this one-year, full-time Experimental Pharmacology and Therapeutics MSc, jointly taught by ...

Tiny worms found in ponds and rivers could be instrumental in treating mental illness, a study has suggested. Research at the University of Reading has found the worms react to brain medicines in a ...

Aim Self-medication is a common practice, often underestimated in terms of its associated risks. This behavior is observed not only among individuals with formal education in healthcare but also among ...

Explore our campus, meet lecturers and current students, and learn more about what it's like to study at Manchester. Visit our Faculty of Biology, Medicine and Health postgraduate research events page ...

The UCL Research Department of Neuroscience, Physiology and Pharmacology (NPP) traces its origins to the founding of the Department of Physiology at UCL in 1828, the first of its kind in England.